SCHEMBL3561807

SCHEMBL3561807

Cc1c(C)c(C)c(S(=O)(=O)Nc2ccccc2CCCc2cccc(C(=O)O)c2)c(C)c1C

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC16A3 O15427 9/20 0.63
KDM4E B2RXH2 2/20 0.46
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
HPGD P15428 1/20 0.46
CRHBP P24387 1/20 0.46
CRHR2 Q13324 1/20 0.46
HSD17B10 Q99714 1/20 0.46
RAB9A P51151 1/20 0.44
AKR1C3 P42330 2/20 0.43
TSHR P16473 1/20 0.42
PTK2B Q14289 1/20 0.42
RAD52 P43351 1/20 0.41
METAP2 P50579 1/20 0.41
CASP3 P42574 1/20 0.41
SENP8 Q96LD8 1/20 0.41
SENP7 Q9BQF6 1/20 0.41
SENP6 Q9GZR1 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3552087 0.93 SLC16A3 (0.68) SLC16A3KDM4EKMT2AMEN1ALDH1A1
SCHEMBL3564318 0.89 SLC16A3 (0.63) SLC16A3KMT2AMEN1ALDH1A1HPGD
SCHEMBL3564726 0.88 SLC16A3 (0.58) SLC16A3KDM4EKMT2AMEN1ALDH1A1
SCHEMBL3554928 0.88 SLC16A3 (0.70) SLC16A3RAD52
SCHEMBL3556460 0.87 SLC16A3 (0.66) SLC16A3KDM4EKMT2ARAB9AAKR1C3
SCHEMBL3557013 0.86 SLC16A3 (0.74) SLC16A3KDM4EKMT2AMEN1RAB9A
SCHEMBL3558496 0.86 SLC16A3 (0.70) SLC16A3KDM4ERAB9AAKR1C3TSHR
Benzene SCHEMBL3553377 0.85 SLC16A3 (0.61) SLC16A3KMT2ARAB9AAKR1C3
SCHEMBL3560711 0.85 SLC16A3 (0.61) SLC16A3KMT2ARAB9AAKR1C3
SCHEMBL3556687 0.85 SLC16A3 (0.65) SLC16A3KDM4EKMT2AMEN1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US claimed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US claimed
US-7816397-B2 Phenylcarboxylic acid derivatives and use thereof for the treatment of diabetes MERCK PATENT GMBH (DE) 2010-10-19 US disclosed
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes MERCK PATENT GMBH (DE) 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045483-A1 Phenylcarboxylic Acid Derivatives and Use Thereof for the Treatment of Diabetes SLC5A1, ALDH7A1, ASS1 SLC16A3 425/4885KDM4E 1045/4885KMT2A 4045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.